Skip to content

National Guideline for Visceral Leishmaniasis

National Guideline for Visceral Leishmaniasis
🏥 Ethiopian Ministry of Health 📅 Year: 2013 📄 Format: PDF ⬇️ Downloads: 23

What this document is

This page hosts the full PDF of the Federal Ministry of Health’s Guideline for Diagnosis, Treatment and Prevention of Leishmaniasis in Ethiopia, Second Edition, June 2013. The file runs to 88 pages. It is the national clinical guideline for visceral leishmaniasis (kala-azar), and it also covers cutaneous leishmaniasis, post kala-azar dermal leishmaniasis (PKDL) and leishmaniasis in people living with HIV.

Why it was written

The foreword explains that visceral leishmaniasis is found mainly in the lowlands of the northwest, central, south and southwest of the country, while the cutaneous form occurs widely across Ethiopia. It puts the annual burden of visceral disease at 2,000 to 4,500 cases and notes that the disease was spreading to new areas through population movement and HIV co-infection. This edition updated the 2006 visceral leishmaniasis guideline for health workers so that it would cover every form of the disease.

Diagnosis

After chapters on the parasite’s life cycle and the clinical picture, Chapter 4 covers diagnosis of visceral leishmaniasis: clinical diagnosis and the laboratory investigations that confirm it. The annexes give step-by-step procedures for the rK39 rapid diagnostic test, the direct agglutination test, lymph node, bone marrow and spleen aspiration, and preparing and examining aspirates.

Treatment

Chapter 5 sets out first-line and second-line regimens for primary visceral leishmaniasis, treatment of relapse, follow-up and treatment failure, what to do when treatment is interrupted, treatment of PKDL, treatment in special groups, concomitant infections, supportive care, prognosis and the practical challenges of treating the disease. Annexes give dosing and precautions for sodium stibogluconate, paromomycin and meglumine antimoniate, plus a treatment algorithm.

Visceral leishmaniasis and HIV

Chapter 6 deals with co-infection: how HIV changes the disease, diagnosis, treatment, management of relapse, and secondary prophylaxis to prevent the disease returning.

Cutaneous leishmaniasis, prevention and reporting

Chapter 7 covers the clinical forms, diagnosis and treatment of cutaneous leishmaniasis in Ethiopia. Chapter 8 covers prevention and control through vector control, health education and social mobilisation, and the information system. The final annexes carry the disease record form, the patient follow-up and discharge card, the quarterly facility report and the registration format.

A note on the date

The file is the June 2013 second edition. The drugs, doses and algorithms in it reflect national practice at that time, so check them against current Ministry of Health guidance and your treatment centre’s protocol before relying on them for patient care.

Related documents in the Hepius library

See also the Third National Neglected Tropical Diseases Strategic Plan 2021-2025, which covers the national programme for leishmaniasis among other NTDs, and the National Guidelines for Comprehensive HIV Prevention, Care and Treatment (February 2018).

Download PDF Free to download — no registration required

Get new Ethiopian clinical guidelines by email

One short message when a new national guideline, protocol or standard is added to this library. The download above stays free either way.

No spam, unsubscribe any time. Privacy policy.

Related documents

Other guidelines and protocols on the same subject.

Browse the full document library →